Menu
Menu
aKavita Darji, MD; bReena Varade, MD; bDaniel West, MD; cEric S. Armbrecht, PhD; bMary A. Guo, MD aSaint Louis University School of Medicine, Saint Louis, Missouri bDepartment of Dermatology, Saint
aKerry Zang, DPM; bRobert Sullivan, BSc (Hons) Podiatry, MSc Pod Surgery, PgCAcup, FIChPA, MInstChP; cSteven Shanks aArizona Institute of Footcare Physicians, Mesa, Arizona bMidleton Foot Clinic Group, Midleton, County Cork,
Douglas C. Wu, MD, PhD; Mitchel P. Goldman, MD Cosmetic Laser Dermatology, San Diego, California Disclosure: Dr. Wu reports no relevant conflicts of interest. Dr. Goldman is a consultant for
aAaron Tabor, MD; bJoseph V. Pergolizzi, Jr., MD; cGuy Marti, MD; cJohn Harmon, MD; dBernard Cohen, MD; aJo Ann LeQuang, BA aGenArmor, Winston-Salem, North Carolina; bNEMA Research, Inc, Naples, Florida;
aShino Bay Aguilera, DO, FAOCD; bLiza Brown, DO; cViviana Andrea Perico, MD aVolunteer Professor, Nova Southeastern University College of Osteopathic Medicine, Department of Dermatology, Fort Lauderdale, Florida bDermatology Resident—PGY3, Larkin
Philip R. Cohen, MD Department of Dermatology, University of California San Diego, La Jolla, California Disclosure: The author reports no relevant conflicts of interest. Abstract Red dot basal cell carcinoma,
